NorthCrest Asset Manangement LLC Decreases Stock Position in Astrana Health, Inc. (NASDAQ:ASTH)

NorthCrest Asset Manangement LLC trimmed its position in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 2.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 448,902 shares of the company's stock after selling 11,993 shares during the quarter. NorthCrest Asset Manangement LLC owned about 0.80% of Astrana Health worth $14,154,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Handelsbanken Fonder AB grew its position in Astrana Health by 4.7% in the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock worth $281,000 after acquiring an additional 400 shares in the last quarter. Quarry LP increased its position in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after purchasing an additional 471 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Astrana Health by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock valued at $773,000 after purchasing an additional 915 shares during the last quarter. Swiss National Bank raised its holdings in Astrana Health by 1.1% during the 4th quarter. Swiss National Bank now owns 88,444 shares of the company's stock valued at $2,789,000 after buying an additional 1,000 shares during the period. Finally, MetLife Investment Management LLC lifted its position in Astrana Health by 4.7% in the fourth quarter. MetLife Investment Management LLC now owns 26,284 shares of the company's stock worth $829,000 after buying an additional 1,173 shares during the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Up 3.0%

Shares of ASTH traded up $0.72 during midday trading on Friday, reaching $25.10. 213,219 shares of the stock were exchanged, compared to its average volume of 291,612. Astrana Health, Inc. has a 52 week low of $23.12 and a 52 week high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The company's 50 day moving average is $29.69 and its two-hundred day moving average is $33.50. The company has a market capitalization of $1.41 billion, a P/E ratio of 19.31, a PEG ratio of 1.37 and a beta of 1.00.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The firm had revenue of $620.39 million for the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. Astrana Health's quarterly revenue was up 53.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.31 EPS. On average, sell-side analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Robert W. Baird cut their price objective on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Bank of America cut their price target on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday, March 4th. Stifel Nicolaus decreased their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Barclays initiated coverage on Astrana Health in a research note on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 target price on the stock. Finally, Truist Financial reduced their price target on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.